AR028969A1 - 3-AZABICICLO DERIVATIVES [3.1.0] USEFUL HEXANE IN THERAPY - Google Patents
3-AZABICICLO DERIVATIVES [3.1.0] USEFUL HEXANE IN THERAPYInfo
- Publication number
- AR028969A1 AR028969A1 ARP010102957A ARP010102957A AR028969A1 AR 028969 A1 AR028969 A1 AR 028969A1 AR P010102957 A ARP010102957 A AR P010102957A AR P010102957 A ARP010102957 A AR P010102957A AR 028969 A1 AR028969 A1 AR 028969A1
- Authority
- AR
- Argentina
- Prior art keywords
- useful
- derivatives
- azabiciclo
- hexane
- therapy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
Compuestos de la formula (1) en la que los sustituyentes son como se definieron en la presente, y los derivados o profármacos farmacéutica o veterinariamente aceptables de éstos son farmacéutica y veterianariamente utiles, en particular se unen a receptores opiáceos (por ejemplo receptores opiáceos mu, kappa y delta). Es probable que sean utiles en el tratamiento de enfermedades o afecciones moduladas por receptores opiáceos, por ejemplo síndrome del intestino irritable, estrenimiento, náuseas, vomitos, pruritos, trastornos alimentarios, sobredosis opiáceas, depresion, adiccion al tabaco, y al alcohol, disfuncion sexual, shock, apoplejía, dano espinal y trauma cerebral.Compounds of the formula (1) in which the substituents are as defined herein, and the pharmaceutically or veterinarily acceptable derivatives or prodrugs thereof are pharmaceutically and veterinarily useful, in particular they bind opioid receptors (eg mu opiate receptors , kappa and delta). They are likely to be useful in the treatment of diseases or conditions modulated by opioid receptors, for example irritable bowel syndrome, constipation, nausea, vomiting, pruritus, eating disorders, opioid overdose, depression, addiction to tobacco, and alcohol, sexual dysfunction , shock, stroke, spinal damage and brain trauma.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0015562.2A GB0015562D0 (en) | 2000-06-23 | 2000-06-23 | Heterocycles |
Publications (1)
Publication Number | Publication Date |
---|---|
AR028969A1 true AR028969A1 (en) | 2003-05-28 |
Family
ID=9894368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010102957A AR028969A1 (en) | 2000-06-23 | 2001-06-21 | 3-AZABICICLO DERIVATIVES [3.1.0] USEFUL HEXANE IN THERAPY |
Country Status (34)
Country | Link |
---|---|
EP (1) | EP1292574A1 (en) |
JP (1) | JP2004512263A (en) |
KR (1) | KR20040002386A (en) |
CN (1) | CN1639121A (en) |
AP (1) | AP2002002698A0 (en) |
AR (1) | AR028969A1 (en) |
AU (1) | AU781837B2 (en) |
BG (1) | BG107329A (en) |
BR (1) | BR0111867A (en) |
CA (1) | CA2412188A1 (en) |
CZ (1) | CZ20023967A3 (en) |
DO (1) | DOP2001000187A (en) |
DZ (1) | DZ3368A1 (en) |
EA (1) | EA005117B1 (en) |
GB (1) | GB0015562D0 (en) |
HR (1) | HRP20020998A2 (en) |
HU (1) | HUP0301228A3 (en) |
IL (1) | IL153427A0 (en) |
IS (1) | IS6637A (en) |
MA (1) | MA26915A1 (en) |
MX (1) | MXPA02012878A (en) |
NO (1) | NO20026168L (en) |
NZ (1) | NZ523141A (en) |
OA (1) | OA12293A (en) |
PA (1) | PA8519401A1 (en) |
PE (1) | PE20020253A1 (en) |
PL (1) | PL365956A1 (en) |
SK (1) | SK17172002A3 (en) |
TN (1) | TNSN01094A1 (en) |
UA (1) | UA73176C2 (en) |
UY (1) | UY26787A1 (en) |
WO (1) | WO2001098267A1 (en) |
YU (1) | YU91802A (en) |
ZA (1) | ZA200210278B (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GEP20084300B (en) * | 2001-10-22 | 2008-02-11 | Pfizer Prod Inc | 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
AU2003242527B2 (en) * | 2002-05-17 | 2008-10-23 | Tioga Pharmaceuticals, Inc. | Use of compounds that are effective as selective opiate receptor modulators |
DE10259245A1 (en) | 2002-12-17 | 2004-07-01 | Merck Patent Gmbh | Derivatives of asimadolin with covalently bound acids |
JP4960217B2 (en) | 2004-02-23 | 2012-06-27 | グラクソ グループ リミテッド | Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors |
GB0507680D0 (en) * | 2005-04-15 | 2005-05-25 | Glaxo Group Ltd | Compounds |
ATE484502T1 (en) * | 2005-06-14 | 2010-10-15 | Glaxo Group Ltd | NEW CONNECTIONS |
US8163927B2 (en) | 2006-04-03 | 2012-04-24 | Glaxo Group Limited | Azabicyclo [3.1.0] hexane derivatives as modulators of dopamine D3 receptors |
CN101677997B (en) | 2007-03-30 | 2012-05-09 | 泰奥加制药公司 | Kappa-opiate agonists for the treatment of diarrhea-predominant and alternating irritable bowel syndrome |
TWI423801B (en) * | 2007-08-27 | 2014-01-21 | Theravance Inc | 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists |
CA2936749C (en) | 2010-06-11 | 2019-07-09 | Joshua R. Giguere | Transition metal-catalyzed processes for the preparation of n-allyl compounds and use thereof |
US9133116B2 (en) | 2010-09-28 | 2015-09-15 | Panacea Biotec Ltd. | Bicyclic compounds |
ES2774349T3 (en) | 2013-11-20 | 2020-07-20 | Sanwa Kagaku Kenkyusho Co | Derived from 3-azabicyclo [3.1.0] hexane and its use for medical purposes |
US10392345B2 (en) | 2015-05-20 | 2019-08-27 | Sanwa Kagaku Kenkyusho Co., Ltd. | Crystal of salt of novel 3-azabicyclo[3.1.0]hexane derivative and pharmaceutical use thereof |
US11702408B2 (en) | 2017-02-17 | 2023-07-18 | Trevena, Inc. | 5-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same |
CA3052479A1 (en) | 2017-02-17 | 2018-08-23 | Trevena, Inc. | 7-membered aza-heterocyclic containing delta-opioid receptor modulating compounds, methods of using and making the same |
CN110352055A (en) | 2017-03-02 | 2019-10-18 | 株式会社三和化学研究所 | The therapeutic agent of alcohol use disorders |
CN108250088B (en) * | 2018-01-04 | 2020-10-30 | 四川之江高新材料股份有限公司 | Preparation method of N, N, N '-trimethyl-N' -hydroxyethyl bisaminoethylether |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3065230A (en) * | 1959-03-16 | 1962-11-20 | Burroughs Wellcome Co | Azabicyclohexanes and method of preparing them |
AR245933A1 (en) * | 1987-04-16 | 1994-03-30 | Lilly Co Eli | Piperidine opioid antagonists |
US5159081A (en) * | 1991-03-29 | 1992-10-27 | Eli Lilly And Company | Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists |
DE4341403A1 (en) * | 1993-12-04 | 1995-06-08 | Basf Ag | N-substituted 3-azabicycloalkane derivatives, their preparation and use |
TWI244481B (en) * | 1998-12-23 | 2005-12-01 | Pfizer | 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
PE20001420A1 (en) * | 1998-12-23 | 2000-12-18 | Pfizer | CCR5 MODULATORS |
-
2000
- 2000-06-23 GB GBGB0015562.2A patent/GB0015562D0/en not_active Ceased
-
2001
- 2001-06-06 DO DO2001000187A patent/DOP2001000187A/en unknown
- 2001-06-07 DZ DZ013368A patent/DZ3368A1/en active
- 2001-06-07 PL PL01365956A patent/PL365956A1/en not_active Application Discontinuation
- 2001-06-07 BR BR0111867-6A patent/BR0111867A/en not_active IP Right Cessation
- 2001-06-07 IL IL15342701A patent/IL153427A0/en unknown
- 2001-06-07 OA OA1200200386A patent/OA12293A/en unknown
- 2001-06-07 SK SK1717-2002A patent/SK17172002A3/en unknown
- 2001-06-07 EA EA200201269A patent/EA005117B1/en not_active IP Right Cessation
- 2001-06-07 YU YU91802A patent/YU91802A/en unknown
- 2001-06-07 AP APAP/P/2002/002698A patent/AP2002002698A0/en unknown
- 2001-06-07 KR KR1020027017503A patent/KR20040002386A/en not_active Application Discontinuation
- 2001-06-07 HU HU0301228A patent/HUP0301228A3/en unknown
- 2001-06-07 EP EP01936728A patent/EP1292574A1/en not_active Withdrawn
- 2001-06-07 CN CNA018116086A patent/CN1639121A/en active Pending
- 2001-06-07 NZ NZ523141A patent/NZ523141A/en unknown
- 2001-06-07 AU AU62591/01A patent/AU781837B2/en not_active Ceased
- 2001-06-07 JP JP2002504223A patent/JP2004512263A/en not_active Withdrawn
- 2001-06-07 CA CA002412188A patent/CA2412188A1/en not_active Abandoned
- 2001-06-07 MX MXPA02012878A patent/MXPA02012878A/en unknown
- 2001-06-07 CZ CZ20023967A patent/CZ20023967A3/en unknown
- 2001-06-07 WO PCT/IB2001/001035 patent/WO2001098267A1/en not_active Application Discontinuation
- 2001-06-12 PA PA20018519401A patent/PA8519401A1/en unknown
- 2001-06-21 PE PE2001000604A patent/PE20020253A1/en not_active Application Discontinuation
- 2001-06-21 UY UY26787A patent/UY26787A1/en not_active Application Discontinuation
- 2001-06-21 AR ARP010102957A patent/AR028969A1/en unknown
- 2001-06-22 TN TNTNSN01094A patent/TNSN01094A1/en unknown
- 2001-07-06 UA UA20021210406A patent/UA73176C2/en unknown
-
2002
- 2002-11-28 IS IS6637A patent/IS6637A/en unknown
- 2002-11-28 BG BG107329A patent/BG107329A/en unknown
- 2002-12-12 HR HR20020998A patent/HRP20020998A2/en not_active Application Discontinuation
- 2002-12-16 MA MA26955A patent/MA26915A1/en unknown
- 2002-12-19 ZA ZA200210278A patent/ZA200210278B/en unknown
- 2002-12-20 NO NO20026168A patent/NO20026168L/en not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR028969A1 (en) | 3-AZABICICLO DERIVATIVES [3.1.0] USEFUL HEXANE IN THERAPY | |
MY138478A (en) | Benzazepine derivatives for the treatment of neurological disorders | |
MXPA04004370A (en) | Polycyclic guanine derivative phosphodiesterase v inhibitors. | |
CA2422698A1 (en) | Indoline derivatives and their use as 5-ht2 receptor ligands | |
GB0329214D0 (en) | Novel compounds | |
WO2007025103A3 (en) | Organic compounds for treating reduced dopamine receptor signalling activity | |
CR9149A (en) | RAPAMYCIN DERIVATIVES AND USES OF THE SAME IN THE TREATMENT OF NEUROLOGICAL DISORDERS | |
MY141200A (en) | Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group | |
ZA200710798B (en) | Pyrazolo [3, 4-D] azepine derivatives as histamine H3 antagonists | |
PT1736157E (en) | Morphinan derivatives as anti-itching agent | |
IL191751A0 (en) | Pyrrolo[2,3-c]pyridine derivatives | |
CR8094A (en) | IMIDAZOL DERIVATIVES ANTAGONISTS OF THE GLUTAMATE RECEIVER | |
WO2006026204A3 (en) | Novel gamma-lactams as beta-secretase inhibitors | |
TW200514781A (en) | Novel compounds | |
WO2005097778A8 (en) | Tetrahydrobenzazepines as histamine h3 receptor ligands | |
NZ597866A (en) | Therapeutic lactams | |
WO2006029210A3 (en) | Acyclic 1,3-diamines and uses therefor | |
WO2007128827A8 (en) | 17-oxymacbecin derivatives and their use in the treatment of cancer and/or b-cell malignancies | |
ECSP014079A (en) | SULFONAMIDE DERIVATIVES | |
SV2002000459A (en) | DERIVATIVES OF SULFONAMIDS REF. X-13840 | |
GB0317491D0 (en) | Organic compounds | |
MX2012006955A (en) | Compounds for the treatment of neurologic disorders. | |
MXPA05001967A (en) | Process for producing indolopyrrolocarbazole derivative. | |
WO2004063164A8 (en) | Process for the preparation of aryl fused polycyclic lactams | |
WO2006106432A3 (en) | 4-arylpiperidine derivatives and use thereof for preparing a medicament for the treatment of cns disorders |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |